Literature DB >> 6859833

Susceptibility of the Bacteroides fragilis group in the United States in 1981.

F P Tally, G J Cuchural, N V Jacobus, S L Gorbach, K E Aldridge, T J Cleary, S M Finegold, G B Hill, P B Iannini, R V McCloskey, J P O'Keefe, C L Pierson.   

Abstract

The minimal inhibitory concentrations of nine antimicrobial agents was determined for over 750 clinical isolates of the Bacteroides fragilis group of anaerobic bacteria collected from nine centers in the United States during 1981. High resistance rates were documented for cefoperazone, cefotaxime, and tetracycline. Cefoxitin had the best activity of the beta-lactam antibiotics, whereas moxalactam and piperacillin had good activities. The resistance rate for clindamycin was 6%. There were no metronidazole- or chloramphenicol-resistant isolates encountered. There were significant differences in susceptibility among the various species of the B. fragilis group, particularly with moxalactam, cefoxitin, and clindamycin. Clustering of clindamycin-, piperacillin-, and cefoxitin-resistant isolates was observed at different hospitals. The variability of resistance rates with the beta-lactam antibiotics and clindamycin indicates that susceptibility testing of significant clinical isolates should be performed to define local resistance patterns.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859833      PMCID: PMC184695          DOI: 10.1128/AAC.23.4.536

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity.

Authors:  B Olsson; C E Nord; T Wadström
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

2.  Chloramphenicol acetyltransferase of Bacteroides fragilis.

Authors:  M L Britz; R G Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

3.  The susceptibility of Bacteroides fragilis to 24 antibiotics.

Authors:  J W Kislak
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

4.  Antibiotic sensitivity of anaerobic bacteria.

Authors:  I Phillips
Journal:  Ann Ist Super Sanita       Date:  1979       Impact factor: 1.663

5.  Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.

Authors:  K Dornbusch; B Olsson-Lijequist; C E Nord
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

6.  Activity of ten antimicrobial agents against anaerobic bacteria.

Authors:  J Dubois; J C Pechère; P Turgeon
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

Review 7.  Experimental animal models for anaerobic infections.

Authors:  A B Onderdonk; D L Kasper; B J Mansheim; T J Louie; S L Gorbach; J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

8.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

9.  Susceptibility of anaerobic bacteria to ten antimicrobial agents.

Authors:  P C Appelbaum; S A Chatterton
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

10.  Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.

Authors:  D K Henderson; A W Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  41 in total

Review 1.  Impact of antimicrobial agents and chemotherapy from 1972 to 1998.

Authors:  M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 2.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.

Authors:  Kenneth E Aldridge; Megan O'Brien
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Authors:  G J Cuchural; F P Tally; N V Jacobus; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe; C Pierson
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

5.  Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics.

Authors:  S Piriz Duran; J Valle Manzano; R Cuenca Valera; S Vadillo Machota
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Authors:  D R Snydman; N V Jacobus; L A McDermott; S Supran; G J Cuchural; S Finegold; L Harrell; D W Hecht; P Iannini; S Jenkins; C Pierson; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 7.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

8.  Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.

Authors:  C J Gill; D L Shungu; S Ponticas
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

9.  Belgian Collaborative Study of the in-vitro susceptibility of the Bacteroides fragilis group. A Belgian Collaborative Study Group.

Authors: 
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

10.  Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.

Authors:  M V Borobio; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.